Drug discovery goes back to school: changing ecosystem of drug discovery and the rising role of academia
Slusher, B.
Journal of the Peripheral Nervous System Jpns 19 Suppl. 2: S2-S4
2014
ISSN/ISBN: 1085-9489 PMID: 25269734 DOI: 10.1111/jns.12079_1
Accession: 052719782
Full Text Article emailed within 0-6 h: $19.90
Related References
Clark, R.L.; Johnston, B.F.; Mackay, S.P.; Breslin, C.J.; Robertson, M.N.; Harvey, A.L. 2010: The Drug Discovery Portal: a resource to enhance drug discovery from academia Drug Discovery Today 15(15-16): 679-683Takebe, T.; Imai, R.; Ono, S. 2018: The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development Clinical and Translational Science 11(6): 597-606
Hojo, T.; Narita, M. 2013: How can we tie drug development seeds to clinical ?--for succeeding in drug discovery by academia-- Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 133(2): 181-182
Scott, W.L.; O'Donnell, M.J. 2009: Distributed Drug Discovery, Part 1: linking academia and combinatorial chemistry to find drug leads for developing world diseases Journal of Combinatorial Chemistry 11(1): 3-13
Isbell, J. 2008: Changing requirements of purification as drug discovery programs evolve from hit discovery Journal of Combinatorial Chemistry 10(2): 150-157
Swistok, J. 2002: The changing role of peptides in drug discovery Abstracts of Papers American Chemical Society 224(1-2): ORGN 609
Shamas-Din, A.; Schimmer, A.D. 2015: Drug discovery in academia Experimental Hematology 43(8): 713-717
Verkman, A.S. 2004: Drug discovery in academia American Journal of Physiology. Cell Physiology 286(3): C465-C474
Frearson, J.; Wyatt, P. 2010: Drug Discovery in Academia- the third way? Expert Opinion on Drug Discovery 5(10): 909-919
Miyata, T. 2011: Drug discovery and development in academia Rinsho Shinkeigaku 51(11): 1084
Miyata, T 2011: Drug discovery and development in academia Rinsho Shinkeigaku 51(11): 1084-1084
Akimoto, H. 2013: Finding solutions for drug discovery in academia Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(6): 297-303
Dalrymple, M.; Taylor, D.; Kettleborough, C.; Bryans, J.; Solari, R. 2006: Academia-industry partnerships in drug discovery Expert Opinion on Drug Discovery 1(1): 1-6
Nagasawa, H. 2011: Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment Journal of Pharmacological Sciences 115(4): 446-452
Roy, A. 2018: Early Probe and Drug Discovery in Academia: A Minireview High-Throughput 7(1)
Frearson, J.A.; Collie, I.T. 2009: HTS and hit finding in academia--from chemical genomics to drug discovery Drug Discovery Today 14(23-24): 1150-1158
Hallock, Y.F.; Cragg, G.M. 2003: National Cooperative Drug Discovery Groups (NCDDGs): a successful model for public private partnerships in cancer drug discovery Pharmaceutical Biology 41(Suppl 1): 78-91
Moraes, C.B.; Witt, G.; Kuzikov, M.; Ellinger, B.; Calogeropoulou, T.; Prousis, K.C.; Mangani, S.; Di Pisa, F.; Landi, G.; Iacono, L.Dello.; Pozzi, C.; Freitas-Junior, L.H.; Dos Santos Pascoalino, B.; Bertolacini, C.P.; Behrens, B.; Keminer, O.; Leu, J.; Wolf, M.; Reinshagen, J.; Cordeiro-da-Silva, A.; Santarem, N.; Venturelli, A.; Wrigley, S.; Karunakaran, D.; Kebede, B.; Pöhner, I.; Müller, W.; Panecka-Hofman, J.; Wade, R.C.; Fenske, M.; Clos, J.; Alunda, Jé.María.; Corral, Mía.Jesús.; Uliassi, E.; Bolognesi, M.Laura.; Linciano, P.; Quotadamo, A 2019: Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform Slas Discovery: Advancing Life Sciences R and D 24(3): 346-361
Harris, D. 2002: Efficient combinatorial chemistry/high throughput screening paradigm for small molecule Drug Discovery Maximizing the discovery of drug candidates and minimizing waste Abstracts of Papers American Chemical Society 224(1-2): BTEC 8
Hu, S.; Yen, Y.; Ann, D.; Wong, D.T. 2007: Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery Drug Discovery Today 12(21-22): 911-916